Introduction Luseogliflozin, a potent, selective sodium blood sugar cotransporter 2 inhibitor, promotes urinary blood sugar excretion (UGE) and reduces plasma blood sugar concentrations. at 0.5, 1, 2.5, and 5?mg, respectively. On Time 7, the areas beneath the concentrationCtime curves for post-meal plasma blood sugar as well as the mean plasma blood sugar for 0C16?h were… Continue reading Introduction Luseogliflozin, a potent, selective sodium blood sugar cotransporter 2 inhibitor,